Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
Marcin Cieślak, Katarzyna Roszek, Magdalena Wujak
Purinergic Signalling (2018) Vol. 15, Iss. 1, pp. 1-15
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The P2X7 Receptor: Central Hub of Brain Diseases
Roberta Andrejew, Ágatha Oliveira‐Giacomelli, Deidiane Elisa Ribeiro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 115
The microglial component of amyotrophic lateral sclerosis
Benjamin Clarke, Rickie Patani
Brain (2020) Vol. 143, Iss. 12, pp. 3526-3539
Open Access | Times Cited: 109
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102
Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
Fazhi Yu, Chenyu Zhu, Qiong Xie, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12196-12212
Closed Access | Times Cited: 56
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Hamideh Zarrinmayeh, Paul R. Territo
Molecular Imaging (2020) Vol. 19
Open Access | Times Cited: 54
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 4, pp. 604-607
Open Access | Times Cited: 50
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
Elisabetta Bonfanti, Tiziana Bonifacino, Stefano Raffaele, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2395-2395
Open Access | Times Cited: 42
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Fabiola De Marchi, Ivana Munitić, Amedeo Amedei, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 958-978
Open Access | Times Cited: 36
Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders
Alexia Duveau, Éléonore Bertin, Éric Boué‐Grabot
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1327-1343
Open Access | Times Cited: 37
P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
Cristina Ruiz‐Ruiz, Francesco Calzaferri, Antonio G. Garcı́a
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 35
Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues
Natasha Vassileff, Laura J. Vella, Harinda Rajapaksha, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1709-1709
Open Access | Times Cited: 35
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
Manling Xie, Praveen N. Pallegar, Sebastian Parusel, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine
Elisabetta De Filippo, Sonja Hinz, Veronica Pellizzari, et al.
Biochemical Pharmacology (2019) Vol. 172, pp. 113718-113718
Closed Access | Times Cited: 31
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice
Diane Ly, Anjila Dongol, Peter Cuthbertson, et al.
Purinergic Signalling (2020) Vol. 16, Iss. 1, pp. 109-122
Open Access | Times Cited: 28
Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment
Giorgia Scarpellino, Tullio Genova, Luca Munaron
Recent Patents on Anti-Cancer Drug Discovery (2019) Vol. 14, Iss. 1, pp. 32-38
Open Access | Times Cited: 28
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
Júlia Leão Batista Simões, Margarete Dulce Bagatini
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 1, pp. 48-58
Open Access | Times Cited: 20
Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
Melissa Talita Wiprich, Carla Denise Bonan
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10649-10649
Open Access | Times Cited: 17
An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates
Sungmin Park, Daeun Kim, Jaeseung Song, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3216-3216
Open Access | Times Cited: 15
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
Cinzia Volonté, Susanna Amadio, Francesco Liguori, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14
Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?
Benjamin Hall, Jonathan G George, Scott P. Allen
PubMed (2022) Vol. 37, Iss. 3, pp. 189-212
Closed Access | Times Cited: 5
Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia
Daniel G. Calame, Isabella Herman, Reza Maroofian, et al.
Annals of Neurology (2022) Vol. 92, Iss. 2, pp. 304-321
Open Access | Times Cited: 5
Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
Takamasa Nukui, Atsushi Matsui, Hideki Niimi, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Purinergic Receptors P2X7 and P2X4 as Markers of Disease Progression in the rd10 Mouse Model of Inherited Retinal Dystrophy
Natalia Martínez‐Gil, Oksana Kutsyr, Agustina Noailles, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14758-14758
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top